CD44 and head and neck squamous cell carcinoma: CD44(+)-HNSCC cells with sh.NANOG showed a 4.2-12.4-fold decrease in invasion and 4.4-6.3-fold decrease in migration compared with that of CD44(+)- HNSCC cells with sh.Scr (Figs. 2a, b).